190 related articles for article (PubMed ID: 26264720)
1. The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defects.
Donze SH; Meijer CR; Kant SG; Zandwijken GR; van der Hout AH; van Spaendonk RM; van den Ouweland AM; Wit JM; Losekoot M; Oostdijk W
Eur J Endocrinol; 2015 Nov; 173(5):611-21. PubMed ID: 26264720
[TBL] [Abstract][Full Text] [Related]
2. SHOX gene variants: growth hormone/insulin-like growth factor-1 status and response to growth hormone treatment.
Shapiro S; Klein GW; Klein ML; Wallach EJ; Fen Y; Godbold JH; Rapaport R
Horm Res Paediatr; 2015; 83(1):26-35. PubMed ID: 25659810
[TBL] [Abstract][Full Text] [Related]
3. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.
Blum WF; Crowe BJ; Quigley CA; Jung H; Cao D; Ross JL; Braun L; Rappold G;
J Clin Endocrinol Metab; 2007 Jan; 92(1):219-28. PubMed ID: 17047016
[TBL] [Abstract][Full Text] [Related]
5. Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone.
Binder G; Schwarze CP; Ranke MB
J Clin Endocrinol Metab; 2000 Jan; 85(1):245-9. PubMed ID: 10634394
[TBL] [Abstract][Full Text] [Related]
6. Impaired GH secretion in patients with SHOX deficiency and efficacy of recombinant human GH therapy.
Iughetti L; Vannelli S; Street ME; Pirazzoli P; Bertelloni S; Radetti G; Capone L; Stasiowska B; Mazzanti L; Gastaldi R; Maggio MC; Predieri B
Horm Res Paediatr; 2012; 78(5-6):279-87. PubMed ID: 23208451
[TBL] [Abstract][Full Text] [Related]
7. SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformity.
Binder G; Renz A; Martinez A; Keselman A; Hesse V; Riedl SW; Häusler G; Fricke-Otto S; Frisch H; Heinrich JJ; Ranke MB
J Clin Endocrinol Metab; 2004 Sep; 89(9):4403-8. PubMed ID: 15356038
[TBL] [Abstract][Full Text] [Related]
8. Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature.
Rappold GA; Fukami M; Niesler B; Schiller S; Zumkeller W; Bettendorf M; Heinrich U; Vlachopapadoupoulou E; Reinehr T; Onigata K; Ogata T
J Clin Endocrinol Metab; 2002 Mar; 87(3):1402-6. PubMed ID: 11889216
[TBL] [Abstract][Full Text] [Related]
9. Auxology is a valuable instrument for the clinical diagnosis of SHOX haploinsufficiency in school-age children with unexplained short stature.
Binder G; Ranke MB; Martin DD
J Clin Endocrinol Metab; 2003 Oct; 88(10):4891-6. PubMed ID: 14557470
[TBL] [Abstract][Full Text] [Related]
10. Safety Outcomes and Near-Adult Height Gain of Growth Hormone-Treated Children with SHOX Deficiency: Data from an Observational Study and a Clinical Trial.
Benabbad I; Rosilio M; Child CJ; Carel JC; Ross JL; Deal CL; Drop SL; Zimmermann AG; Jia N; Quigley CA; Blum WF
Horm Res Paediatr; 2017; 87(1):42-50. PubMed ID: 28002818
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency.
Scalco RC; Melo SS; Pugliese-Pires PN; Funari MF; Nishi MY; Arnhold IJ; Mendonca BB; Jorge AA
J Clin Endocrinol Metab; 2010 Jan; 95(1):328-32. PubMed ID: 19926713
[TBL] [Abstract][Full Text] [Related]
12. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial.
Blum WF; Ross JL; Zimmermann AG; Quigley CA; Child CJ; Kalifa G; Deal C; Drop SL; Rappold G; Cutler GB
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1383-92. PubMed ID: 23720786
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of SHOX haploinsufficiency among short statured children.
Marstrand-Joergensen MR; Jensen RB; Aksglaede L; Duno M; Juul A
Pediatr Res; 2017 Feb; 81(2):335-341. PubMed ID: 27814343
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone therapy in patients with short stature homeobox-gene (SHOX) deficiency.
Iughetti L; Madeo S; Predieri B
J Endocrinol Invest; 2010 Jun; 33(6 Suppl):34-8. PubMed ID: 21057184
[TBL] [Abstract][Full Text] [Related]
15. Clinical and radiological characteristics of 22 children with SHOX anomalies and familial short stature suggestive of Léri-Weill Dyschondrosteosis.
Salmon-Musial AS; Rosilio M; David M; Huber C; Pichot E; Cormier-Daire V; Nicolino M
Horm Res Paediatr; 2011; 76(3):178-85. PubMed ID: 21912078
[TBL] [Abstract][Full Text] [Related]
16. [Growth Hormone treatment in children with Growth Hormone deficiency, idiopathic short stature, SHOX gene mutation, small for gestational age and Turner syndrome].
Griffero González M; González Navarrete D; Tolosa Navarro F; López Cuevas P; Rodríguez Convertino F; Román Reyes R
Andes Pediatr; 2024 Apr; 95(2):151-158. PubMed ID: 38801362
[TBL] [Abstract][Full Text] [Related]
17. Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion.
Živičnjak M; Schnabel D; Staude H; Even G; Marx M; Beetz R; Holder M; Billing H; Fischer DC; Rabl W; Schumacher M; Hiort O; Haffner D;
J Clin Endocrinol Metab; 2011 Dec; 96(12):E2097-105. PubMed ID: 21994957
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone and gonadotropin-releasing hormone analog therapy in haploinsufficiency of SHOX.
Ogata T; Onigata K; Hotsubo T; Matsuo N; Rappold G
Endocr J; 2001 Jun; 48(3):317-22. PubMed ID: 11523902
[TBL] [Abstract][Full Text] [Related]
19. Short stature due to SHOX deficiency: genotype, phenotype, and therapy.
Binder G
Horm Res Paediatr; 2011 Feb; 75(2):81-9. PubMed ID: 21325865
[TBL] [Abstract][Full Text] [Related]
20. The sitting height/height ratio for age in healthy and short individuals and its potential role in selecting short children for SHOX analysis.
Malaquias AC; Scalco RC; Fontenele EG; Costalonga EF; Baldin AD; Braz AF; Funari MF; Nishi MY; Guerra-Junior G; Mendonca BB; Arnhold IJ; Jorge AA
Horm Res Paediatr; 2013; 80(6):449-56. PubMed ID: 24296787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
